Despite a significant improvement in symptoms, around 20% of patients discontinued treatment due to adverse events.A Parkinson’s disease drug has been effective in reducing the symptoms of treatment-resistant depression.Led by the UK’s University of Oxford, the trial (ISRCTN84666271) found pramipexole to be substantially effective at reducing the symptoms of treatment-resistant depression when added to ongoing […]
